Light J, Boucher M, Baskin-Miller J, Winstead M
J Blood Med. 2023; 14:279-293.
PMID: 37082003
PMC: 10112470.
DOI: 10.2147/JBM.S383472.
Saleh M, Mallipeddi V, Ali A
Cureus. 2021; 12(12):e12167.
PMID: 33489579
PMC: 7813152.
DOI: 10.7759/cureus.12167.
Al-Saqladi A, Maddi D, Al-Sadeeq A
Anemia. 2020; 2020:7080264.
PMID: 32908695
PMC: 7469078.
DOI: 10.1155/2020/7080264.
Brendel C, Negre O, Rothe M, Guda S, Parsons G, Harris C
Mol Ther Methods Clin Dev. 2020; 17:589-600.
PMID: 32300607
PMC: 7150438.
DOI: 10.1016/j.omtm.2020.03.015.
Madhi F, Kamdem A, Jung C, Carlier-Gonod A, Biscardi S, Busca J
J Clin Med. 2019; 8(11).
PMID: 31683997
PMC: 6912589.
DOI: 10.3390/jcm8111839.
Oxygen-dependent flow of sickle trait blood as an in vitro therapeutic benchmark for sickle cell disease treatments.
Lu X, Chaudhury A, Higgins J, Wood D
Am J Hematol. 2018; 93(10):1227-1235.
PMID: 30033564
PMC: 6604607.
DOI: 10.1002/ajh.25227.
Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition.
Mwesigwa S, Moulds J, Chen A, Flanagan J, Sheehan V, George A
Transfusion. 2017; 58(3):726-735.
PMID: 29210071
PMC: 5847445.
DOI: 10.1111/trf.14431.
Red Blood Cell Alloimmunization in Sickle Cell Disease Patients in Tanzania.
Meda E, Magesa P, Marlow T, Reid C, Roberts D, Makani J
East Afr J Public Health. 2017; 11(2):775-780.
PMID: 28979065
PMC: 5624511.
Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman.
Alkindi S, AlMahrooqi S, AlHinai S, AlMarhoobi A, Al-Hosni S, Daar S
Mediterr J Hematol Infect Dis. 2017; 9(1):e2017013.
PMID: 28293401
PMC: 5333756.
DOI: 10.4084/MJHID.2017.013.
Magnetic resonance imaging in pediatric sickle cell anemia.
Zhang X, Li C, Li Q
Exp Ther Med. 2016; 12(2):555-558.
PMID: 27446243
PMC: 4950809.
DOI: 10.3892/etm.2016.3417.
Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.
Kaushal M, Byrnes C, Khademian Z, Duncan N, Luban N, Miller J
PLoS One. 2016; 11(4):e0153244.
PMID: 27116614
PMC: 4845996.
DOI: 10.1371/journal.pone.0153244.
Hematopoietic Stem Cell Transplantation in Adult Sickle Cell Disease: Problems and Solutions.
Ozdogu H, Boga C
Turk J Haematol. 2015; 32(3):195-205.
PMID: 25912490
PMC: 4563194.
DOI: 10.4274/tjh.2014.0311.
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
Meschia J, Bushnell C, Boden-Albala B, Braun L, Bravata D, Chaturvedi S
Stroke. 2014; 45(12):3754-832.
PMID: 25355838
PMC: 5020564.
DOI: 10.1161/STR.0000000000000046.
Hypertransfusion therapy in sickle cell disease in Nigeria.
Adewoyin A, Obieche J
Adv Hematol. 2014; 2014:923593.
PMID: 25177350
PMC: 4142279.
DOI: 10.1155/2014/923593.
Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery.
Choe S, Terman D, Rivers A, Rivera J, Lottenberg R, Sorg B
J Control Release. 2013; 171(2):184-92.
PMID: 23871960
PMC: 4162096.
DOI: 10.1016/j.jconrel.2013.07.008.
Quantitative MRI analysis of salivary glands in sickle cell disease.
Liao J, Saito N, Ozonoff A, Jara H, Steinberg M, Sakai O
Dentomaxillofac Radiol. 2012; 41(8):630-6.
PMID: 23166360
PMC: 3528199.
DOI: 10.1259/dmfr/31672000.
Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller S, Kim H, Weiner D, Wager C, Gallagher D, Styles L
Transfusion. 2012; 53(4):704-9.
PMID: 22804353
PMC: 5096391.
DOI: 10.1111/j.1537-2995.2012.03796.x.
Pharmacoeconomic considerations in treating iron overload in patients with β-thalassaemia, sickle cell disease and myelodysplastic syndromes in the US: a literature review.
Zhang B, Donga P, Corral M, Sasane M, Miller J, Pashos C
Pharmacoeconomics. 2011; 29(6):461-74.
PMID: 21452907
DOI: 10.2165/11589250-000000000-00000.
CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions.
Jang J, Hod E, Spitalnik S, Frenette P
J Clin Invest. 2011; 121(4):1397-401.
PMID: 21383500
PMC: 3069787.
DOI: 10.1172/JCI45336.
Delayed hemolytic transfusion reaction in sickle cell disease.
Scheunemann L, Ataga K
Am J Med Sci. 2010; 339(3):266-9.
PMID: 20051821
PMC: 2837790.
DOI: 10.1097/MAJ.0b013e3181c70e14.
